Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CMS Unconvinced On PET Scans For Bone Metastasis; CED Data Not Enough

This article was originally published in The Gray Sheet

Executive Summary

While National Oncologic PET Registry data has been effective in persuading CMS to remove evidence-development restrictions from positron emission tomography coverage policies in the past, NOPR data was not enough to support coverage of PET scans to identify bone metastasis in a Dec. 15 national coverage determination.


Related Content

Bending To Overwhelming Feedback, CMS Softens Stance On PET For Solid Tumors
Imaging Registry Begins: Coverage-With-Evidence Policy Gets A Second Wind